Rasbelon 1.5mg (Rasburicase Vials) 1.5mg

Rasbelon 1.5mg is a prescription medication containing rasburicase, a urate oxidase enzyme used to manage uric acid levels. This 1.5mg vial formulation helps prevent complications from high uric acid, such as tumor lysis syndrome. Store between 2–8°C to maintain potency. Consult a healthcare provider for suitability.

Strength

1.5mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Celon Laboratories PVT.LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rasbelon 1.5mg is used to lower uric acid levels in the blood, particularly in patients undergoing cancer treatments that may cause tumor lysis syndrome. It works by converting uric acid into a more soluble form for easier elimination. This medication is typically prescribed for short-term use during high-risk chemotherapy or radiation therapy. It is not intended for chronic conditions like gout.

Side Effects

Rasbelon 1.5mg helps reduce uric acid buildup in the bloodstream, which may alleviate symptoms associated with high uric acid levels. Patients may notice improved comfort during cancer treatments when uric acid is properly managed. The medication works systemically to support kidney function by preventing uric acid crystallization. Effects are generally observed within hours of administration.

Precautions & Warnings

Rasbelon 1.5mg should be handled with care, as it is a sterile injectable product. Store vials refrigerated between 2–8°C and protect from light. Avoid freezing or shaking the vial. Use only as directed by a healthcare professional. Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid this medication due to risk of hemolysis. Always check for signs of allergic reactions during administration.

Avoid Interactions

Rasbelon 1.5mg has a low potential for drug interactions due to its enzymatic mechanism. However, caution is advised when used with other medications that affect uric acid levels, such as allopurinol. No significant interactions with common drugs like antibiotics or pain relievers have been reported. Always inform your healthcare provider about all medications being taken. Alcohol consumption should be avoided during treatment.

Frequently Asked Questions

Rasbelon 1.5mg is used to lower uric acid levels in the blood, particularly during cancer treatments that may cause tumor lysis syndrome.

Rasbelon 1.5mg vials should be stored refrigerated between 2–8°C and protected from light.

No, Rasbelon 1.5mg is not indicated for chronic conditions like gout; it is used for short-term management during cancer therapy.

Common side effects may include headache, nausea, or allergic reactions. Severe reactions are rare but require immediate medical attention.

The safety of Rasbelon 1.5mg during pregnancy has not been established. Consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.